Inactivated, split-virion influenza vaccine

BIOLOGICAL6 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

InfluenzaMyxovirus InfectionOrthomyxoviridae InfectionOrthomyxoviridae InfectionsOrthomyxovirus Infections

Phase 2

Immunogenicity Study of the Influenza Vaccine in Adults

CompletedNCT00258934

Sanofi Pasteur, a Sanofi CompanyInfluenza, Orthomyxoviridae Infections

Start: 2005-09-30End: 2008-09-30Updated: 2014-01-14

Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

CompletedNCT00296829

Sanofi Pasteur, a Sanofi CompanyInfluenza, Myxovirus Infection, Orthomyxoviridae Infection

Start: 2006-01-31End: 2007-02-28Target: 1080Updated: 2014-01-14

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

CompletedNCT00703651

Sanofi Pasteur, a Sanofi CompanyInfluenza, Myxovirus Infection, Orthomyxoviridae Infection

Start: 2003-09-30End: 2006-07-31Updated: 2014-01-13

Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

CompletedNCT00776438

Sanofi Pasteur, a Sanofi CompanyInfluenza, Myxovirus Infection, Orthomyxovirus Infections

Start: 2007-09-30End: 2009-04-30Updated: 2015-06-17

Phase 3

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

CompletedNCT00383526

Sanofi Pasteur, a Sanofi CompanyInfluenza, Myxovirus Infection, Orthomyxoviridae Infection

Start: 2006-09-30End: 2009-09-30Updated: 2014-01-14

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

CompletedNCT00391053

Sanofi Pasteur, a Sanofi CompanyInfluenza, Myxovirus Infection, Orthomyxoviridae Infection

Start: 2006-10-31End: 2008-02-29Updated: 2016-04-14

Related Papers

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

2009-07-01285 citations

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.

2009-04-0267 citations

Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

2008-09-01187 citations